Clinical Trial Update: Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating repeated super-selective intraarterial infusion of bevacizumab (Avastin) for relapsed glioblastoma and anaplastic astro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Northwell Health | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1, Phase 2 | Status: RECRUITING